MicroStrategy has stopped issuing its preferred STRC shares, which raised nearly $2 billion in May, and is now funding Bitcoin purchases primarily through common stock sales and cash reserves. This shift reflects a change in strategy amid market conditions, aiming for more shareholder engagement but causing slower Bitcoin accumulation. Critics like Peter Schiff note that STRC shares trading near par value limit new funding via preferred shares, while CEO Michael Saylor highlights STRC's reduced volatility as a benefit for income investors. The company holds a $5.02 billion reserve to cover dividends, but the future funding approach will be clearer with upcoming filings, which investors and the market will watch closely as a signal of institutional Bitcoin confidence.
MicroStrategy's funding shift away from STRC shares to common stock sales and cash reserves is notable. For readers following the broader cryptocurrency market, here is Pluang's market snapshot as of Oct 05, 2026 06:21 WIB: out of 50 major cryptocurrencies, 31 rose and 17 fell. Among them, GRT rose 4.97% to Rp529 with 82% sell orders, ONE fell 4.12% to Rp43 with 56% sell orders, and XTZ rose 3.68% to Rp5,945 with 74% sell orders.
The Europe portable washing machine market is projected to grow from $2.52 billion in 2025 to $3.58 billion by 2034, with a CAGR of 3.98%. Growth is fueled by urban compact living, rising demand for space-saving appliances, increased consumer mobilit...
Food Lion has agreed to purchase five Winn-Dixie stores in Southern Georgia, expanding its presence to 51 stores in the state. This acquisition will bring Food Lion's total new store openings in 2026 to 15, exceeding its original target of 10. The st...
Cerebras Systems' stock fell 19.6% on June 24, 2026, after missing Q1 earnings estimates and revealing increased costs from renting third-party capacity. A subsequent report in October questioned the durability of Cerebras' chips and alleged inflated...
The global medical imaging workstations market is projected to grow from USD 6.20 billion in 2026 to USD 12.55 billion by 2036, at a CAGR of 7.3%. Growth is fueled by rising chronic disease prevalence, increased diagnostic imaging demand, and advance...
The global sacral neuromodulation market is projected to grow from $1.37 billion in 2026 to $3.92 billion by 2036, at an 11.1% CAGR. Growth is fueled by rising cases of urinary and fecal incontinence, demand for minimally invasive treatments, and an ...
